UDP-glucose 4-epimerase: Difference between revisions

From WikiMD's Medical Encyclopedia

CSV import
 
CSV import
Line 1: Line 1:
'''UDP-glucose 4-epimerase''' is an [[enzyme]] that catalyzes the reversible conversion of [[UDP-glucose]] (UDPG) to [[UDP-galactose]] (UDPGal). This reaction is a critical step in the [[metabolism]] of [[carbohydrates]], playing a key role in the interconversion of [[glucose]] and [[galactose]] in the body. UDP-glucose 4-epimerase is essential for the proper utilization of galactose, a sugar found in milk and other dairy products, and is involved in the biosynthesis of [[glycoproteins]], [[glycolipids]], and [[proteoglycans]].
== UDP-glucose 4-epimerase ==


== Function ==
[[UDP-glucose 4-epimerase]] is an enzyme that plays a crucial role in the [[metabolism]] of [[galactose]]. It catalyzes the reversible conversion of [[UDP-glucose]] to [[UDP-galactose]], a key step in the [[Leloir pathway]] of galactose metabolism. This enzyme is encoded by the [[GALE]] gene in humans.
UDP-glucose 4-epimerase operates in the [[Leloir pathway]], the primary pathway for galactose metabolism. The enzyme ensures that UDP-galactose produced during the digestion of galactose-containing foods can be converted back to UDP-glucose, which can then enter the [[glycolysis]] pathway or be used in other biosynthetic processes. This equilibrium between UDP-glucose and UDP-galactose is crucial for maintaining the balance of these two sugars in the body.


== Structure ==
=== Structure ===
The enzyme is a homodimer, meaning it consists of two identical subunits. Each subunit binds one molecule of [[NAD+]] (nicotinamide adenine dinucleotide), which is required for the enzyme's catalytic activity. The structure of UDP-glucose 4-epimerase has been elucidated through [[X-ray crystallography]], revealing details about its active site and the mechanism by which it catalyzes the epimerization of UDP-glucose.
UDP-glucose 4-epimerase is a homodimeric enzyme, meaning it consists of two identical subunits. Each subunit binds a molecule of [[NAD+]], which is essential for its catalytic activity. The enzyme's active site is where the epimerization reaction occurs, involving the transient reduction of the sugar moiety by NAD+.


== Mechanism ==
[[File:Human_GALE_bound_to_NADH_and_UDP-glucose.png|thumb|right|300px|Structure of human GALE bound to NADH and UDP-glucose.]]
UDP-glucose 4-epimerase catalyzes the conversion of UDP-glucose to UDP-galactose through a two-step mechanism. First, the enzyme induces the removal of a hydrogen atom from the 4' position of the glucose molecule, creating a 4-keto intermediate. Then, a different hydrogen atom is added to the opposite side of the 4-keto group, resulting in the formation of UDP-galactose. This reaction is dependent on the presence of NAD+, which acts as a cofactor, undergoing reversible reduction and oxidation during the process.


== Clinical Significance ==
=== Function ===
Mutations in the gene encoding UDP-glucose 4-epimerase can lead to [[galactosemia]], a rare genetic disorder characterized by an inability to properly metabolize galactose. This can result in the accumulation of toxic substances in the body, leading to liver damage, [[intellectual disability]], and other serious health problems. Early diagnosis and dietary restrictions of galactose can manage the symptoms of galactosemia.
The primary function of UDP-glucose 4-epimerase is to interconvert UDP-glucose and UDP-galactose. This reaction is vital for the proper utilization of galactose obtained from the diet. In the [[Leloir pathway]], galactose is first phosphorylated to galactose-1-phosphate, which is then converted to UDP-galactose. UDP-glucose 4-epimerase facilitates the conversion of UDP-galactose to UDP-glucose, which can then enter glycolysis or be used in the synthesis of glycogen and other glycoproteins.


== See Also ==
[[File:Leloir_pathway.png|thumb|right|300px|Diagram of the Leloir pathway of galactose metabolism.]]
* [[Galactose metabolism]]
 
=== Clinical significance ===
Mutations in the GALE gene can lead to a condition known as [[epimerase-deficiency galactosemia]]. This disorder is characterized by an inability to properly metabolize galactose, leading to the accumulation of toxic substances in the body. Symptoms can include [[jaundice]], [[hepatomegaly]], and [[cataracts]]. The severity of the condition can vary, with some individuals experiencing mild symptoms and others having more severe manifestations.
 
=== Related enzymes ===
UDP-glucose 4-epimerase is part of a family of enzymes known as [[epimerases]], which catalyze the inversion of stereochemistry at specific carbon atoms in sugar molecules. Other related enzymes include [[UDP-glucuronate 4-epimerase]] and [[UDP-N-acetylglucosamine 4-epimerase]].
 
== Related pages ==
* [[Galactosemia]]
* [[Leloir pathway]]
* [[Leloir pathway]]
* [[Galactosemia]]
* [[NAD+]]
* [[Glycolysis]]
* [[Metabolism]]


== References ==
== References ==
<references/>
{{Reflist}}


[[Category:Enzymes]]
[[Category:Enzymes]]
[[Category:Metabolism]]
[[Category:Metabolism]]
[[Category:Carbohydrate chemistry]]
[[Category:Galactose metabolism]]
 
{{enzyme-stub}}

Revision as of 21:00, 9 February 2025

UDP-glucose 4-epimerase

UDP-glucose 4-epimerase is an enzyme that plays a crucial role in the metabolism of galactose. It catalyzes the reversible conversion of UDP-glucose to UDP-galactose, a key step in the Leloir pathway of galactose metabolism. This enzyme is encoded by the GALE gene in humans.

Structure

UDP-glucose 4-epimerase is a homodimeric enzyme, meaning it consists of two identical subunits. Each subunit binds a molecule of NAD+, which is essential for its catalytic activity. The enzyme's active site is where the epimerization reaction occurs, involving the transient reduction of the sugar moiety by NAD+.

File:Human GALE bound to NADH and UDP-glucose.png
Structure of human GALE bound to NADH and UDP-glucose.

Function

The primary function of UDP-glucose 4-epimerase is to interconvert UDP-glucose and UDP-galactose. This reaction is vital for the proper utilization of galactose obtained from the diet. In the Leloir pathway, galactose is first phosphorylated to galactose-1-phosphate, which is then converted to UDP-galactose. UDP-glucose 4-epimerase facilitates the conversion of UDP-galactose to UDP-glucose, which can then enter glycolysis or be used in the synthesis of glycogen and other glycoproteins.

Diagram of the Leloir pathway of galactose metabolism.

Clinical significance

Mutations in the GALE gene can lead to a condition known as epimerase-deficiency galactosemia. This disorder is characterized by an inability to properly metabolize galactose, leading to the accumulation of toxic substances in the body. Symptoms can include jaundice, hepatomegaly, and cataracts. The severity of the condition can vary, with some individuals experiencing mild symptoms and others having more severe manifestations.

Related enzymes

UDP-glucose 4-epimerase is part of a family of enzymes known as epimerases, which catalyze the inversion of stereochemistry at specific carbon atoms in sugar molecules. Other related enzymes include UDP-glucuronate 4-epimerase and UDP-N-acetylglucosamine 4-epimerase.

Related pages

References